Buprenorphine vs Pembrolizumab

Buprenorphine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Pembrolizumab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Pembrolizumab — Antibody.